Panama's Medicine Market

In a sector worth $307 million a year, 10% of the market is supplied by laboratories in the Panamanian capital, and the remaining 90% by international pharmaceutical companies.

Tuesday, October 21, 2014

The biggest challenges faced by domestic enterprises are the obstacles in importing raw materials, skilled labor, and delays in the registration process, among other things. "... This makes the domestic industry less competitive compared with international laboratories which bring in to the country finished products or those ready for packaging. "

Luz Marina Pardo, manager of commercial operations at Medipan, founded with Panamanian capital, told Martesfinanciero.com that "...We do not buy from manufacturers, but to intermediaries. If the intermediary is in the United States, but the product comes from China, you must apply for a certificate of origin in Tokyo, because Panama has no commercial relationship with China. This whole process results in higher costs for laboratories, and added to this is the time it takes to complete the whole process."

"...Pharmaceutical companies believe that the Panamanian Department of Pharmacies and Drug at the MoH should allow a single registration to be made for imported materials, valid for several years, rather than carrying out the process every time the product comes in. "

¿Busca soluciones de inteligencia comercial para su empresa?

Do you need more information about your business sector?

Request more information:









this site is protected by reCAPTCHA and Google's privacy policy and terms of service.
Need assistance? Contact us
(506) 4001-6423


More on this topic

Salvadoran Medicines in Costa Rica

July 2017

Laboratorios Paill has started the brand certification process in the Costa Rican market, and plans to start exporting its products next year.

The manufacturer of oral, injectable and ophthalmological drugs already exports its products to neighboring countries such as Guatemala, Nicaragua and Honduras, and plans to start 

Peruvian Pharmaceutical Company to Operate in Panama

October 2014

The ESKE Group has announced te opening of a distribution hub in Panama City to redistribute its generic lines imported from India and Europe and those manufactured in Peru.

Group ESKE, an importer of generic drugs from India and Europe and others that it manufactures at its plant in Peru, intends to establish in Panama a distribution hub for the entire region.

High Price of Medicines in Costa Rica

December 2012

A study by the Universidad de Costa Rica notes that one company controls the distribution of 80% of drugs sold, with price differences of up to 1,000%.

An article in Nacion.com reports that there is "little or no competition in the private sector of medicine, product of an industry that is "highly concentrated", causing Costa Rica to have higher drug prices compared to other Central American countries."

Pharmaceutical Industry in Central America

March 2011

A study of the regional competition in the wholesale supply chain and retail distribution of medicines in Central America.

The study aims at analyzing competition of the drug sector in Costa Rica, El Salvador, Guatemala, Honduras, Nicaragua and Panama from a regional perspective in order to strengthen coordination among these countries in promoting and protecting competition and universal access to safe medicines.

ok